Literature DB >> 20678570

Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins.

Kalavathi Dasuri1, Philip J Ebenezer, Le Zhang, Sun Ok Fernandez-Kim, Romina M Uranga, Elena Gavilán, Alessia Di Blasio, Jeffrey N Keller.   

Abstract

Maintaining protein homeostasis is vital to cell viability, with numerous studies demonstrating a role for proteasome inhibition occurring during the aging of a variety of tissues and, presumably, contributing to the disruption of cellular homeostasis during aging. In this study we sought to elucidate the differences between neurons and astrocytes in regard to basal levels of protein synthesis, proteasome-mediated protein degradation, and sensitivity to cytotoxicity after proteasome inhibitor treatment. In these studies we demonstrate that neurons have an increased vulnerability, compared to astrocyte cultures, to proteasome-inhibitor-induced cytotoxicity. No significant difference was observed between these two cell types in regard to the basal rates of protein synthesis, or basal rates of protein degradation, in the pool of short-lived proteins. After proteasome inhibitor treatment neuronal crude lysates were observed to undergo greater increases in the levels of ubiquitinated and oxidized proteins and selectively exhibited increased levels of newly synthesized proteins accumulating within the insoluble protein pool, compared to astrocytes. Together, these data suggest a role for increased oxidized proteins and sequestration of newly synthesized proteins in the insoluble protein pool, as potential mediators of the selective neurotoxicity after proteasome inhibitor treatment. The implications for neurons exhibiting increased sensitivity to acute proteasome inhibitor exposure, and the corresponding changes in protein homeostasis observed after proteasome inhibition, are discussed in the context of both aging and age-related disorders of the nervous system.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678570      PMCID: PMC3175605          DOI: 10.1016/j.freeradbiomed.2010.07.014

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  44 in total

1.  Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion.

Authors:  A L Bulteau; K C Lundberg; K M Humphries; H A Sadek; P A Szweda; B Friguet; L I Szweda
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins.

Authors:  Q Ding; J N Keller
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

Review 3.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Possible involvement of proteasome inhibition in aging: implications for oxidative stress.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  Mech Ageing Dev       Date:  2000-01-24       Impact factor: 5.432

5.  Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

Authors:  I Kruman; A J Bruce-Keller; D Bredesen; G Waeg; M P Mattson
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

Review 6.  Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles.

Authors:  M A Smith; L M Sayre; V M Monnier; G Perry
Journal:  Mol Chem Neuropathol       Date:  1996 May-Aug

7.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Y A Lam; C M Pickart; A Alban; M Landon; C Jamieson; R Ramage; R J Mayer; R Layfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.

Authors:  J N Keller; M S Kindy; F W Holtsberg; D K St Clair; H C Yen; A Germeyer; S M Steiner; A J Bruce-Keller; J B Hutchins; M P Mattson
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

Review 9.  The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.

Authors:  Benoit I Giasson; Harry Ischiropoulos; Virginia M-Y Lee; John Q Trojanowski
Journal:  Free Radic Biol Med       Date:  2002-06-15       Impact factor: 7.376

Review 10.  At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules.

Authors:  J W Yewdell; U Schubert; J R Bennink
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  11 in total

1.  Amino acid analog toxicity in primary rat neuronal and astrocyte cultures: implications for protein misfolding and TDP-43 regulation.

Authors:  Kalavathi Dasuri; Philip J Ebenezer; Romina M Uranga; Elena Gavilán; Le Zhang; Sun O K Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  J Neurosci Res       Date:  2011-05-23       Impact factor: 4.164

2.  Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Sun Ok Fernandez-Kim; Joseph Francis; Nithya Mariappan; Zhanguo Gao; Jianping Ye; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-17       Impact factor: 4.310

Review 3.  Walking the oxidative stress tightrope: a perspective from the naked mole-rat, the longest-living rodent.

Authors:  Karl A Rodriguez; Ewa Wywial; Viviana I Perez; Adriant J Lambert; Yael H Edrey; Kaitlyn N Lewis; Kelly Grimes; Merry L Lindsey; Martin D Brand; Rochelle Buffenstein
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Proteasome alterations during adipose differentiation and aging: links to impaired adipocyte differentiation and development of oxidative stress.

Authors:  Kalavathi Dasuri; Le Zhang; Philip Ebenezer; Sun Ok Fernandez-Kim; Annadora J Bruce-Keller; Luke I Szweda; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2011-08-10       Impact factor: 7.376

5.  cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons.

Authors:  Natura Myeku; Hu Wang; Maria E Figueiredo-Pereira
Journal:  Neurosci Lett       Date:  2012-09-05       Impact factor: 3.046

6.  Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons.

Authors:  Qian Huang; Hu Wang; Seth W Perry; Maria E Figueiredo-Pereira
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

7.  Altered composition of liver proteasome assemblies contributes to enhanced proteasome activity in the exceptionally long-lived naked mole-rat.

Authors:  Karl A Rodriguez; Yael H Edrey; Pawel Osmulski; Maria Gaczynska; Rochelle Buffenstein
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

8.  Morphological Changes within the Rat Lateral Ventricle after the Administration of Proteasome Inhibitors.

Authors:  Sławomir Wójcik; Jan Henryk Spodnik; Jerzy Dziewiątkowski; Edyta Spodnik; Janusz Moryś
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

Review 9.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

10.  Overexpression of Atg5 in mice activates autophagy and extends lifespan.

Authors:  Jong-Ok Pyo; Seung-Min Yoo; Hye-Hyun Ahn; Jihoon Nah; Se-Hoon Hong; Tae-In Kam; Sunmin Jung; Yong-Keun Jung
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.